摘要
目的探讨中西药联合治疗涂阳肺结核的临床价值。方法将128例初、复治涂阳耐药肺结核患者随机分为治疗组(64例)和对照组(64例),治疗组采用中国结核病控制项目制定的标准化疗方案与中药抗痨丸联合治疗,对照组单用标准化疗方案,观察对比疗效。结果疗程结束时,治疗组痰菌阴转率(90.6%)、病灶累计吸收率(85.9%)、空洞闭合率(60.7%)、临床症状改善率(89.0%)明显高于对照组的81.3%、64.1%、37.5%、59.4%。中药抗痨丸与西药联合治疗无任何不良作用,对改善患者症状有明显效果。结论中西药联合治疗涂阳肺结核,症状改善迅速、疗效满意,是一种安全有效、可靠的治疗方法。
Objective To investigate the clinical value of combination of Chinese and Western medicine in the treatment of smear-positive pulmonary tuberculosis. Methods One hundred and twenty eight cases of early, retreatment smear, positive pulmonary tuberculosis patients were randomly divided into treatment group （64 cases） and control group （64 cases）. The treatment group was given China TB control project standard chemotherapy and traditional Chinese medicine anti tuberculosis pill combined with treatment, the control group only received standard chemotherapy regimens. The efficacy of two groups were observed and compared. Results At the end of the treatment, the treatment group of sputum negative conversion rate （90.6%）, lesions accumulated absorption rate （85.9%）, the cavity closure rate （60.7%）, the clinical symptom improvement rate （9.0%） was higher than that in control group of 81.3%, 64.1%, 37.5%, 59.4%. Traditional Chinese medicine anti tuberculosis pill combined with western medicine treatment had not any adverse effects, could improve the patient＇s symptoms and had obvious effect. Conclusion The combination of Chinese and Western medicine in the treatment of smear-positive pulmonary tuberculosis, symptoms improve rapidly, curative effect is satisfactory, is a safe, effective, reliable treatment method.
出处
《中国当代医药》
2013年第7期90-91,94,共3页
China Modern Medicine
关键词
结核
涂阳
中西药物
联合
Tuberculosis
Smear positive
Chinese and Western medicine
Combination
